Doctors typically prescribe Zytiga (abiraterone acetate) with prednisone for treating prostate cancer. This combination offers superior results compared to Zytiga alone.
Why Prednisone?
Prednisone, a corticosteroid, works synergistically with Zytiga. It inhibits certain enzymes that can counteract Zytiga’s effects, leading to improved tumor suppression. This increases Zytiga’s efficacy in reducing prostate cancer growth and spread.
Dosage and Administration
The specific dosage of both drugs depends on individual patient factors and is determined by your oncologist. Commonly, prednisone is administered at a low daily dose. It’s usually taken orally, alongside Zytiga which is also taken orally.
Potential Side Effects
While this combination is highly effective, it’s important to be aware of potential side effects, such as increased blood sugar, fluid retention, and weight gain. Prednisone, specifically, can impact mood and sleep patterns. Your physician will monitor you closely for any adverse reactions. Open communication with your doctor about any symptoms is key to managing potential issues.
Alternatives and Individualized Treatment
While the Zytiga-prednisone combination is a standard approach, treatment strategies are personalized. Factors like your overall health, cancer stage, and response to treatment influence the specific treatment plan. Some patients may tolerate Zytiga without prednisone, but this decision is made on a case-by-case basis, always involving a careful risk-benefit analysis with your healthcare provider. Always discuss any concerns or questions you have with your doctor.
